Influenza And Beyond: Sanofi Pasteur R&D Chief Talks Strategy

 
• By Lucie Ellis-Taitt
  
Syringe
Sanofi Pasteur to target acquired recombinant flu vaccine at 50-plus population • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from AI

More from Digital Technologies